AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015
May 5, 2015
30583_dirs_2015-05-05_8eb25300-cda2-43b8-8733-cd80f30ba6c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-04-30
Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-30 | Common Stock | A | 1425 | $51.2635 | Acquired | 90060 | Direct |
| 2015-05-01 | Common Stock | S | 414 | $114.5941 | Acquired | 89646 | Direct |
Footnotes
F1: The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 30, 2014 to April 30, 2015.
F2: Trade made pursuant to a 10b5-1 plan executed on March 2, 2015.
F3: The price in column 4 is a weighted average price. The price actually received ranged from $113.32 to $115.85. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.